Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Csgalnact1em1flox/Cya
Common Name:
Csgalnact1-flox
Product ID:
S-CKO-07724
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Csgalnact1-flox
Strain ID
CKOCMP-234356-Csgalnact1-B6J-VB
Gene Name
Csgalnact1
Product ID
S-CKO-07724
Gene Alias
4732435N03Rik; CSGalNAcT-1
Background
C57BL/6JCya
NCBI ID
234356
Modification
Conditional knockout
Chromosome
8
Phenotype
MGI:2442354
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Csgalnact1em1flox/Cya mice (Catalog S-CKO-07724) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000078350
NCBI RefSeq
NM_172753
Target Region
Exon 5
Size of Effective Region
~1.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Csgalnact1, which encodes chondroitin sulfate N-acetylgalactosaminyltransferase 1, is a key enzyme in the biosynthesis of sulfated glycosaminoglycans chondroitin and dermatan sulfate [2,3,6]. It initiates chondroitin sulfate (CS) chain biosynthesis on the GAG-protein linker region tetrasaccharide [6]. CS, a major component of proteoglycans in the extracellular matrix, is involved in numerous biological processes, such as synaptic plasticity in the brain and the synthesis of connective tissues [1,4].

Gene knockout mouse models have provided crucial insights into Csgalnact1's functions. T1KO mice (lacking Csgalnact1) show extensive axon regeneration following spinal cord injury and loss of onset of ocular dominance plasticity, suggesting its importance in neuronal plasticity and axon regeneration [1]. Biochemically, the loss of this enzyme reduces CS amount by about 50% in various brain regions, leading to abnormal behaviors in tests like the open-field test, acoustic startle response, and social preference, indicating its role in regulating CS-dependent perineuronal nets (PNNs) [4]. In addition, CSGalNAcT1-KO mice have milder symptoms in experimental autoimmune encephalomyelitis compared to wild-type mice, suggesting CS's contribution to the induction phase of this disease [5]. Diabetic T1KO mice are more resistant to diabetic neuropathy, with more stable pericyte-endothelial cell interactions and less up-regulated Smad2/3 phosphorylation in the transforming growth factor β signaling pathway [7]. In humans, biallelic loss-of-function mutations in Csgalnact1 cause a mild skeletal dysplasia with features like joint hypermobility, axial malalignment, and advanced bone age [2,3,6].

In conclusion, Csgalnact1 plays essential roles in neuronal plasticity, axon regeneration, immune-related neurological diseases, and skeletal development. The study of Csgalnact1 KO mouse models has significantly advanced our understanding of its functions in these disease-related biological processes, providing potential insights for treating related disorders.

References:
1. Igarashi, Michihiro, Takeuchi, Kosei, Sugiyama, Sayaka. 2017. Roles of CSGalNAcT1, a key enzyme in regulation of CS synthesis, in neuronal regeneration and plasticity. In Neurochemistry international, 119, 77-83. doi:10.1016/j.neuint.2017.10.001. https://pubmed.ncbi.nlm.nih.gov/28987564/
2. Meyer, R, Schacht, S, Buschmann, L, Kurth, I, Elbracht, M. 2019. Biallelic CSGALNACT1-mutations cause a mild skeletal dysplasia. In Bone, 127, 446-451. doi:10.1016/j.bone.2019.07.016. https://pubmed.ncbi.nlm.nih.gov/31325655/
3. Mizumoto, Shuji, Janecke, Andreas R, Sadeghpour, Azita, Yamada, Shuhei, Vodopiutz, Julia. 2019. CSGALNACT1-congenital disorder of glycosylation: A mild skeletal dysplasia with advanced bone age. In Human mutation, 41, 655-667. doi:10.1002/humu.23952. https://pubmed.ncbi.nlm.nih.gov/31705726/
4. Yoshioka, Nozomu, Miyata, Shinji, Tamada, Atsushi, Takeuchi, Kosei, Igarashi, Michihiro. 2017. Abnormalities in perineuronal nets and behavior in mice lacking CSGalNAcT1, a key enzyme in chondroitin sulfate synthesis. In Molecular brain, 10, 47. doi:10.1186/s13041-017-0328-5. https://pubmed.ncbi.nlm.nih.gov/28982363/
5. Inada, Rino, Miyamoto, Katsuichi, Tanaka, Noriko, Igarashi, Michihiro, Kusunoki, Susumu. . Chondroitin sulfate N-acetylgalactosyltransferase-1 knockout shows milder phenotype in experimental autoimmune encephalomyelitis than in wild type. In Glycobiology, 31, 260-265. doi:10.1093/glycob/cwaa072. https://pubmed.ncbi.nlm.nih.gov/32839819/
6. Vodopiutz, Julia, Mizumoto, Shuji, Lausch, Ekkehart, Sugahara, Kazuyuki, Janecke, Andreas R. 2016. Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity. In Human mutation, 38, 34-38. doi:10.1002/humu.23070. https://pubmed.ncbi.nlm.nih.gov/27599773/
7. Ishiguro, Hajime, Ushiki, Takashi, Honda, Atsuko, Igarashi, Michihiro, Sone, Hirohito. 2024. Reduced chondroitin sulfate content prevents diabetic neuropathy through transforming growth factor-β signaling suppression. In iScience, 27, 109528. doi:10.1016/j.isci.2024.109528. https://pubmed.ncbi.nlm.nih.gov/38595797/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest